二项概率的贝叶斯非劣效检验:作为Fisher精确检验的扩展
针对二项反应概率的非劣效试验,提出基于条件功效先验的贝叶斯非劣效检验框架,可灵活纳入历史数据,并给出后验概率的精确表达;证明贝叶斯后验概率与Fisher精确检验P值的关系,从而将本方法解释为Fisher精确检验的贝叶斯非劣效扩展,使优效性与非劣效性可在同一框架下处理;通过蒙特卡洛模拟、HIV临床试验数据应用及基于历史数据的样本量计算进行说明。
要点
- 提出贝叶斯非劣效检验框架,通过条件功效先验灵活纳入历史数据。
- 给出非劣效后验概率的精确表达,避免复杂Appell超几何函数或近似方法。
- 证明贝叶斯后验概率与Fisher精确检验P值的关系,使优效与非劣效统一处理。
核心结论
- 本方法可解释为Fisher精确检验的贝叶斯非劣效扩展,并可在同一框架下处理优效性与非劣效性。
研究设计与样本
- 方法学研究,提出贝叶斯非劣效检验框架并通过蒙特卡洛模拟评估操作特性、应用于真实HIV临床试验数据及基于历史数据进行样本量计算。
主要发现
- 在某些温和条件下给出了非劣效后验概率的精确表达,并展示了贝叶斯后验概率与Fisher精确检验P值之间的关系。
关键数值与推荐
- 非劣效试验中贝叶斯方法评估H1:π1>π2-Δ为真的后验概率,其中Δ>0为非劣效界值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Noninferiority trials have recently gained importance for the clinical trials of drugs and medical devices. In these trials, most statistical methods have been used from a frequentist perspective, and historical data have been used only for the specification of the noninferiority margin Δ>0. In contrast, Bayesian methods, which have been studied recently are advantageous in that they can use historical data to specify prior distributions and are expected to enable more efficient decision making than frequentist methods by borrowing information from historical trials. In the case of noninferiority trials for response probabilities π1 ,π2 , Bayesian methods evaluate the posterior probability of H1 :π1 >π2 -Δ being true. To numerically calculate such posterior probability, complicated Appell hypergeometric function or approximation methods are used. Further, the theoretical relationship between Bayesian and frequentist methods is unclear. In this work, we give the exact expression of the posterior probability of the noninferiority under some mild conditions and propose the Bayesian noninferiority test framework which can flexibly incorporate historical data by using the conditional power prior. Further, we show the relationship between Bayesian posterior probability and the P value of the Fisher exact test. From this relationship, our method can be interpreted as the Bayesian noninferior extension of the Fisher exact test, and we can treat superiority and noninferiority in the same framework. Our method is illustrated through Monte Carlo simulations to evaluate the operating characteristics, the application to the real HIV clinical trial data, and the sample size calculation using historical data.
引用
- Doi M, Takahashi F, Kawasaki Y, et al. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test. Stat Med. 2017. PMID: 28960376. doi:10.1002/sim.7495
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。